Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-17T19:14:13.319Z Has data issue: false hasContentIssue false

Clinical evidence on the role of oestrogens in the development of the breasts

Published online by Cambridge University Press:  05 December 2011

Z. Laron
Affiliation:
Institute of Pediatric and Adolescent Endocrinology, Beilinson Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49 100, Israel
R. Kauli
Affiliation:
Institute of Pediatric and Adolescent Endocrinology, Beilinson Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49 100, Israel
A. Pertzelan
Affiliation:
Institute of Pediatric and Adolescent Endocrinology, Beilinson Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Petah Tikva 49 100, Israel
Get access

Synopsis

Girls start their puberty including breast development around age 8. Though the best correlation found is that with oestradiol, most girls still have at the onset of breast development oestrogen levels in the normal range for adult males. Therefore, it seems that oestrogen receptor sensitivity plays an important role in breast development. An important insight into the hormonal interplay in breast development was obtained when comparing the effect of exogenous oestrogens in forty-five girls with four different aetiologies of oestrogen deficiency: gonadal dysgenesis (GD). 17-alpha hydroxylase deficiency (17-OHase def), isolated gonadotrophin deficiency (IGnD) and multiple pituitary hormone deficiencies (MPHD). None of the girls had any breast development in the absence of oestrogens. Treatment with oestrogen was given in an identical manner to all. In GD, in whom the hypothalamic-pituitary functions were normal, treatment led to full development of breasts in a relatively short period. In IGnD and MPHD, breast development was incomplete even after years of oestrogen treatment. The conspicuous difference of the hormonal status between GD and IGnD and MPHD is that the latter two groups lack gonadotrophins, while in GD and 17-OHase def. these hormones are pathologically elevated. Thus the gonadotrophins seem to play an important role in mammary gland development. In the girl with 17-OHase def., it was also found that cortisol is necessary for normal breast development. A girl with hyperprolactinaemia due to a microadenoma had delayed puberty including slow breast development. Upon bromocriptine treatment the prolactin fell, the oestrogens rose and puberty including breast development occurred. Patients with Laron-type dwarfism (isolated IGF-I deficiency) have been found to have normal breast development.

Type
Research Article
Copyright
Copyright © Royal Society of Edinburgh 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Apter, D. 1980. Serum steroids and pituitary hormones in female puberty: A partly longitudinal study. Clinical Endocrinology 12, 107120.CrossRefGoogle ScholarPubMed
Bidlingmaier, F. & Knorr, D. 1978. Oestrogens – Physiological and Clinical Aspects, Pediatric and adolescent endocrinology, Vol. 4, pp. 7681. Basel: Karger.Google Scholar
Biglieri, E. G. 1979. Mechanisms establishing the mineralocorticoid hormone patterns in the 17-alpha hydroxylase deficiency syndrome. Journal of Steroid Biochemistry 11, 653657.CrossRefGoogle ScholarPubMed
Boyar, R. M., Rosenfeld, R. S., Kapen, S., Finkelstein, J. W., Roffwarg, H. P., Weitzman, E. D. & Hellman, L. 1974. Human puberty: simultaneous augmented secretion of luteinizing hormone and testosterone during sleep. Journal of Clinical Investigation 54, 609618.CrossRefGoogle ScholarPubMed
Boyar, R. M., Rosenfeld, R. S., Kapen, S., Finkelstein, J. W., Roffwarg, H. P., Weitzman, E. D. & Katz, J. 1977. Twenty-four hour gonadotropin secretory patterns in anorexia nervosa. In Anorexia Nervosa, ed. Vigerski, R. A., pp. 177187. New York: Raven Press.Google ScholarPubMed
Brown, J. P., Harrison, P. & Smith, M. A. 1978. Oestrogen and pregnanediol excretion through childhood, mernarche and first ovulation. Journal of Biosocial Science. Supplement 5, 4362.CrossRefGoogle Scholar
Ceriani, P. L. 1974. Hormones and other factors controlling growth in the mammary gland. Journal of Investigative Dermatology 63, 93103.CrossRefGoogle ScholarPubMed
De Leon, D. D., Bakker, B., Wilson, D. M., Hintz, R. L. & Rosenfeld, R. G. 1988. Demonstration of insulin like growth factor (1GF-I and -II) receptors and binding protein in human breast cancer cell lines. Biochemical and Biophysical Research Communications 152, 398405.CrossRefGoogle Scholar
Dickerman, Z., Prager Lewin, R. & Laron, Z. 1976. The effect of repeated injections of synthetic LH-RH on the response of plasma LH and FSH in young hypogonadotrophic hypogonadal patients. Fertility & Sterility 21, 162166.CrossRefGoogle Scholar
Grumbach, M. M., Grave, G. D. & Mayer, F. E. 1974. Control of Onset of Puberty. New York: John Wiley & Sons.Google Scholar
Hsueh, A. J. W. & Jones, P. B. C. 1981. Extrapituitary actions of gonadotropin releasing hormone. Endocrine Reviews 2, 437461.CrossRefGoogle ScholarPubMed
Ilicki, A., Prager Lewin, R., Kauli, R., Kaufman, H., Schachter, A. & Laron, Z. 1984. Premature thelarche – natural history and sex hormone secretion in 68 girls. Acta Paediatrica Scandinavica 73, 756762.CrossRefGoogle ScholarPubMed
Kauli, R., Schoenfeld, A., Ovadia, Y., Matz, S., Assa, S. & Laron, Z. 1985. Delayed puberty and hypoplastic uterus associated with hyperprolactinemia: successful treatment with bromocriptine. Hormone Research 22, 6873.CrossRefGoogle ScholarPubMed
Laron, Z. 1983. Deficiencies of growth hormone and somatomedins in man. In Special Topics in Endocrinology & Metabolism, eds Cohen, M. P. & Foa, P. P., Vol. 5, pp. 149199. New York: Alan R. Liss Inc.Google Scholar
Laron, Z. 1984. Laron type dwarfism (hereditary somatomedin deficiency): a review. In Advances in Internal Medicine and Pediatrics, eds Frick, P., Von Harnack, G. A., Kochsiek, K., Martini, G. A. & Prader, A., pp. 117150. Berlin: Springer.Google Scholar
Laron, Z., Sarel, R. & Pertzelan, A. 1980. Puberty in Laron type dwarfism. European Journal of Pediatrics 134, 7983.CrossRefGoogle ScholarPubMed
Laron, Z., Prager Lewin, R. & Dickerman, Z. 1984. Diagnostic uses of LH-RH. In LH-RH and its Analogs – Contraceptive and Therapeutic Applications, eds Vickery, B. H., Nestor, J. J. Jr., & Hafez, E. S. E., pp. 367374. Lancaster: MTP Press.Google Scholar
Lee, P. A., Kenakis, T., Winer, J. & Matsenbaugh, S. 1976. Puberty in girls: correlation of serum levels of gonadotropins, prolactin, androgens, oestrogens, and progestins with physical changes. Journal of Clinical Endocrinology and Metabolism 43, 775784.CrossRefGoogle ScholarPubMed
Neu, R. L. & Gardner, L. I. 1975. Turner's syndrome – hormone therapy. In Endocrine and Genetic Diseases of Childhood, ed. Gardner, L. I., 2nd edn, pp. 801802. New York: W. B. Saunders.Google Scholar
Ojeda, S. 1980. The endocrinology of sexual development. Federal Proceedings 39, 23532354.Google Scholar
Pertzelan, A., Assa, S., Keret, R. & Laron, Z. 1977. Prolactin secretion in girls with isolated gonadotrophin deficiency. Clinical Endocrinology 7, 429431.CrossRefGoogle ScholarPubMed
Pertzelan, A., Assa, S., Keret, R., Yalon, L., Kauli, R. & Laron, Z. 1982. A comparative study on the effect of oestrogen substitution therapy on breast development in girls with hypo- and hypergonadotrophic hypogonadism. Clinical Endocrinology 16, 359368.CrossRefGoogle Scholar
Rosenfeld, R. L. & Fung, V. S. 1974. The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teenagers. The Journal of Pediatrics 85, 830837.CrossRefGoogle Scholar
Tanner, J. M. 1962. Growth at Adolescence, 2nd edn, p. 28. Oxford: Blackwell Scientific Publications.Google Scholar